[Federal Register: April 5, 2005 (Volume 70, Number 64)]
[Notices]               
[Page 17260-17261]
From the Federal Register Online via GPO Access [wais.access.gpo.gov]
[DOCID:fr05ap05-57]                         

=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration

 
Manufacturer of Controlled Substances; Notice of Registration

    By Notice dated December 21, 2004, and published in the Federal 
Register on January 4, 2005, (70 FR 388-389), Cambrex Charles City, 
Inc., 1205 11th Street, Charles City, Iowa 50616, made application by 
renewal and on October 13, 2004 by letter to the Drug Enforcement 
Administration (DEA) to be registered as a bulk manufacturer of the 
basic classes of controlled substances listed in Schedule II:

------------------------------------------------------------------------
                    Drug                               Schedule
------------------------------------------------------------------------
Amphetamine (1100).........................  II
Methylphenidate (1724).....................  II
Dextropropoxyphene (9273)..................  II

[[Page 17261]]


Fentanyl (9801)............................  II
------------------------------------------------------------------------

    The company plans to manufacture the listed controlled substances 
in bulk for distribution to its customers.
    No comments or objections have been received. DEA has considered 
the factors in 21 U.S.C. 823(a) and determined that the registration of 
Cambrex Charles City, Inc. to manufacture the listed basic classes of 
controlled substances is consistent with the public interest at this 
time. DEA has investigated Cambrex Charles City, Inc. to ensure that 
the company's registration is consistent with the public interest. The 
investigation has included inspection and testing of the company's 
physical security systems, verification of the company's compliance 
with state and local laws, and a review of the company's background and 
history. Therefore, pursuant to 21 U.S.C. 823, and in accordance with 
21 CFR 1301.33(a), the above named company is granted registration as a 
bulk manufacturer of the basic classes of controlled substances listed.

    Dated: March 25, 2005.
William J. Walker,
Deputy Assistant Administrator, Office of Diversion Control, Drug 
Enforcement Administration.
[FR Doc. 05-6701 Filed 4-4-05; 8:45 am]

BILLING CODE 4410-09-P